Trial Review

Please note that the ANZCTR will be unattended on Friday 25th April due to the ANZAC Day public holiday. Submissions and updates will not be processed during that time.

The ANZCTR website is back online for trial registration and updates. We apologise for any inconvenience caused while the site was inactive.



Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12608000209392
Ethics application status
Approved
Date submitted
9/04/2008
Date registered
18/04/2008
Date last updated
25/06/2010
Type of registration
Prospectively registered

Titles & IDs
Public title
Acute myocardial infarction: investigating evidence-based practice to address the rural disadvantage.
Scientific title
The impact of clinical pathways on acute myocardial infarction management in rural hospitals.
Secondary ID [1] 252103 0
Impact of clinical pathways on time to thrombolysis in rural hospitals.
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute myocardial infarction 3024 0
Condition category
Condition code
Cardiovascular 3174 3174 0 0
Coronary heart disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
A five step process over 3 months of implementing clinical pathways for AMI management in rural emergency departments.
The intervention sites will participate in the 5 step evidence-based implementation process described below. The control group will receive a hard copy of the relevant NHF guidelines. The evidence-based 5 step intervention within emergency departments to implement clinical pathways will be a combination of processes proposed by Doherty and Jones (2006) and Kinsman et al. (2007). In brief, the three month implementation process involves:
(b) Engaging clinicians
Group discussions will be held with medical and nursing staff regarding barriers and facilitators for clinical pathways whilst local clinicians will be recruited as Research Assistants. This role will involve activities such as participating in the clinical pathway development, as described below, and promoting the study amongst other staff members.
(c) Clinical pathway development
Hospital-specific clinical pathways will be developed collaboratively at each emergency department.
(d) Reminders
Reminder visits will occur twice following implementation to liaise with staff. Research Assistants will also be asked to remind medical and nursing staff about the clinical pathway.
(e) Education
Education sessions will be held during implementation to review evidence underpinning the clinical pathway. All staff will receive written material regarding thrombolytic drugs.
(f) Audit and feedback
Audit results reflecting compliance with the clinical pathway and thrombolysis administration will be communicated to staff twice during the implementation of the clinical pathway.
Intervention code [1] 2765 0
Other interventions
Comparator / control treatment
Distribution of clinical guidelines without implementation of clinical pathways.
Control group
Historical

Outcomes
Primary outcome [1] 4060 0
Proportion of eligible patients receiving a thrombolytic drug.
Timepoint [1] 4060 0
During treatment in the emergency department. Door-to-needle time for thrombolysis.
Secondary outcome [1] 6832 0
Adherence to clinical pathway via the RE-AIM framework.
Timepoint [1] 6832 0
During emergency department treatment.

Eligibility
Key inclusion criteria
AMI patients meeting criteria for delivery of thrombolytic drugs.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
AMI not primary diagnosis.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Six hospitals involved - three will be randomised to intervention and three to control. Randomisation of hospitals to intervention or control will be the result of a coin toss conducted by the research team off-site and concealed from the study sites.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by coin-tossing.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Cluster trial.
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
2/06/2008
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
140
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment postcode(s) [1] 814 0
3550
Recruitment postcode(s) [2] 815 0
3500
Recruitment postcode(s) [3] 816 0
3630
Recruitment postcode(s) [4] 817 0
3564
Recruitment postcode(s) [5] 818 0
3350

Funding & Sponsors
Funding source category [1] 3279 0
University
Name [1] 3279 0
Faculty of Medicine, Nursing and Health Sciences
Country [1] 3279 0
Australia
Primary sponsor type
University
Name
Faculty of Medicine, Nursing and Health Sciences
Address
Monash University VIC 3800
Country
Australia
Secondary sponsor category [1] 2931 0
None
Name [1] 2931 0
Address [1] 2931 0
Country [1] 2931 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 5266 0
Monash University
Ethics committee address [1] 5266 0
Ethics committee country [1] 5266 0
Australia
Date submitted for ethics approval [1] 5266 0
14/03/2008
Approval date [1] 5266 0
02/04/2008
Ethics approval number [1] 5266 0
CF08/0532 - 2008000253

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 28511 0
Address 28511 0
Country 28511 0
Phone 28511 0
Fax 28511 0
Email 28511 0
Contact person for public queries
Name 11668 0
Leigh Kinsman
Address 11668 0
School of Rural Health Monash University PO Box 666 Bendigo VIC 3552
Country 11668 0
Australia
Phone 11668 0
61354409022
Fax 11668 0
61354409080
Email 11668 0
[email protected]
Contact person for scientific queries
Name 2596 0
Leigh Kinsman
Address 2596 0
Monash University PO Box 666 Bendigo VIC 3552
Country 2596 0
Australia
Phone 2596 0
61354409022
Fax 2596 0
61354409080
Email 2596 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.